bf/NYSE:BBLN_icon.jpeg

COM:BABYLONHEALTH

Babylon Health

  • Stock

USD

Last Close

0.64

28/06 20:00

Market Cap

14.10M

Beta: -

Volume Today

419.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
net income
-140.29M
-
-188.03M
34.03%
-374.51M
99.18%
-221.45M
40.87%
depreciation and amortization
2.50M
-
14.49M
480.41%
35.00M
141.62%
12.05M
65.58%
deferred income tax
-5.56M
-
4.64M
183.45%
-1.47M
131.77%
-66K
95.52%
stock based compensation
7.97M
-
9.56M
19.97%
46.31M
384.53%
34.56M
25.38%
change in working capital
8.74M
-
1.60M
81.69%
25.67M
1,503.19%
-26.09M
201.64%
accounts receivables
inventory
accounts payables
other working capital
-26.09M
-
other non cash items
-16.97M
-
14.32M
184.34%
123.14M
760.15%
-110.41M
189.66%
net cash provided by operating activities
-143.61M
-
-143.43M
0.13%
-145.87M
1.70%
-311.41M
113.49%
investments in property plant and equipment
-37.95M
-
-37.23M
1.91%
-40.22M
8.05%
-8.51M
78.83%
acquisitions net
-35.67M
-
-16.59M
53.51%
purchases of investments
-2.21M
-
sales maturities of investments
2.21M
-
other investing activites
1.01M
-
673K
33.69%
2.01M
199.11%
net cash used for investing activites
-36.94M
-
-72.23M
95.54%
-54.80M
24.13%
-8.51M
84.46%
debt repayment
-17.25M
-
-1.54M
91.07%
-93.59M
5,973.13%
common stock issued
320.33M
-
12.10M
96.22%
229.31M
1,795.76%
80M
65.11%
common stock repurchased
dividends paid
other financing activites
49.44M
-
89.50M
81.03%
226.48M
153.04%
93.17M
58.86%
net cash used provided by financing activities
352.52M
-
100.06M
71.62%
362.20M
261.99%
173.18M
52.19%
effect of forex changes on cash
-3.11M
-
2.47M
179.22%
-716K
129.02%
-11.36M
1,486.45%
net change in cash
168.86M
-
-113.13M
167.00%
160.82M
242.16%
-219.11M
236.24%
cash at beginning of period
46.03M
-
214.89M
366.83%
101.76M
52.65%
262.58M
158.05%
cash at end of period
214.89M
-
101.76M
52.65%
262.58M
158.05%
43.48M
83.44%
operating cash flow
-143.61M
-
-143.43M
0.13%
-145.87M
1.70%
-311.41M
113.49%
capital expenditure
-37.95M
-
-37.23M
1.91%
-40.22M
8.05%
-8.51M
78.83%
free cash flow
-181.56M
-
-180.66M
0.50%
-186.09M
3.01%
-319.92M
71.92%

All numbers in USD (except ratios and percentages)